Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of inflammation-associated disorders using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors

Treatment of inflammation-associated disorders using interleukin-1&bgr;-converting enzyme (ICE)/CED-3 family inhibitors

US Patent 6693096 · Granted Feb 17, 2004

Estimated economic value: $2,498,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted imidazo[1,2-A]quinazolines as inhibitors of PARG2025
Substituted imidazo[1,2-a]quinazolines and imidazo [1,2-a]pyrido[4,3-e]pyrimidin2024
Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavo2022
Method of improving stability of sweet enhancer and composition containing stabi2021
Compounds useful as modulators of TRPM82021
Absorbent article with fluid control features2020
Processes and intermediates for making sweet taste enhancers2020
Compounds useful as modulators of TRPM82019
Processes and intermediates for making sweet taste enhancers2019
Method of improving stability of sweet enhancer and composition containing stabi2019
Processes and intermediates for making sweet taste enhancers2018
Phenanthroline phosphonic acid derivative and preparation method therefor and ap2018